Selecta Biosciences Garners $9,350,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c6495fd4-cf4d-4bf0-af16-1cc1a5895ab6
Date
6/18/2014
Company Name
Selecta Biosciences
Mailing Address
480 Arsenal St. Building One Watertown, MA 02472 USA
Company Description
Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications.
Website
http://www.selectabio.com
Transaction Type
Venture Equity
Transaction Amount
$9,350,000
Transaction Round
Undisclosed
Proceeds Purposes
Selecta continues to advance key immune activation programs, with newly-announced funding totaling $9.35 million from the Bill & Melinda Gates Foundation and NIH/NIDA.
M&A Terms
Venture Investor
Venture Investor